Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacs (PACS) EBITDA (2023 - 2025)

Pacs' EBITDA history spans 3 years, with the latest figure at $94.7 million for Q4 2025.

  • For Q4 2025, EBITDA rose 31.55% year-over-year to $94.7 million; the TTM value through Dec 2025 reached $280.1 million, up 186.11%, while the annual FY2025 figure was $309.6 million, 151.55% up from the prior year.
  • EBITDA for Q4 2025 was $94.7 million at Pacs, up from $86.3 million in the prior quarter.
  • Across five years, EBITDA topped out at $94.7 million in Q4 2025 and bottomed at -$32.1 million in Q2 2024.
  • The 3-year median for EBITDA is $42.9 million (2023), against an average of $45.2 million.
  • The largest annual shift saw EBITDA crashed 36.92% in 2024 before it surged 275.67% in 2025.
  • A 3-year view of EBITDA shows it stood at $36.4 million in 2023, then soared by 97.73% to $72.0 million in 2024, then soared by 31.55% to $94.7 million in 2025.
  • Per Business Quant, the three most recent readings for PACS's EBITDA are $94.7 million (Q4 2025), $86.3 million (Q3 2025), and $51.0 million (Q2 2025).